Literature DB >> 30184317

Can Mitochondrial DNA be CRISPRized: Pro and Contra.

Romuald Loutre1, Anne-Marie Heckel1, Anna Smirnova1, Nina Entelis1, Ivan Tarassov1.   

Abstract

Mitochondria represent a chimera of macromolecules encoded either in the organellar genome, mtDNA, or in the nuclear one. If the pathway of protein targeting to different sub-compartments of mitochondria was relatively well studied, import of small noncoding RNAs into mammalian mitochondria still awaits mechanistic explanations and its functional issues are often not understood thus raising polemics. At the same time, RNA mitochondrial import pathway has an obvious attractiveness as it appears as a unique natural mechanism permitting to address nucleic acids into the organelles. Deciphering the function(s) of imported RNAs inside the mitochondria is extremely complicated due to their relatively low abundance, which suggests their regulatory role. We previously demonstrated that mitochondrial targeting of small noncoding RNAs able to specifically anneal with the mutant mitochondrial DNA led to a decrease of the mtDNA heteroplasmy level by inhibiting mutant mtDNA replication. We then demonstrated that increasing level of expression of such antireplicative recombinant RNAs increases significantly the antireplicative effect. In this report, we present a new data investigating the possibility to establish a CRISPR-Cas9 system targeting mtDNA exploiting of the pathway of RNA import into mitochondria. Mitochondrially addressed Cas9 versions and a set of mitochondrially targeted guide RNAs were tested in vitro and in vivo and their effect on mtDNA copy number was demonstrated. So far, the system appeared as more complicated for use than previously found for nuclear DNA, because only application of a pair of guide RNAs produced the effect of mtDNA depletion. We discuss, in a critical way, these results and put them in a broader context of polemics concerning the possibilities of manipulation of mtDNA in mammalians. The findings described here prove the potential of the RNA import pathway as a tool for studying mtDNA and for future therapy of mitochondrial disorders. © The Authors. IUBMB Life published by Wiley Periodicals, Inc. on behalf of International Union of Biochemistry and Molecular Biology, 70(12):1233-1239, 2018.
© 2018 The Authors. IUBMB Life published by Wiley Periodicals, Inc. on behalf of International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  zzm321990mitochondria; CRISPR; Cas9; heteroplasmy; human; mitochondrila DNA

Mesh:

Substances:

Year:  2018        PMID: 30184317     DOI: 10.1002/iub.1919

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  13 in total

1.  Heterologous Inferential Analysis (HIA) and Other Emerging Concepts: In Understanding Mitochondrial Variation In Pathogenesis: There is no More Low-Hanging Fruit.

Authors:  Antón Vila-Sanjurjo; Paul M Smith; Joanna L Elson
Journal:  Methods Mol Biol       Date:  2021

2.  Lipophilic Conjugates for Carrier-Free Delivery of RNA Importable into Human Mitochondria.

Authors:  Ilya Dovydenko; Mariya Meschaninova; Anne-Marie Heckel; Ivan Tarassov; Alya Venyaminova; Nina Entelis
Journal:  Methods Mol Biol       Date:  2021

3.  Translation initiation in mammalian mitochondria- a prokaryotic perspective.

Authors:  Shreya Ahana Ayyub; Umesh Varshney
Journal:  RNA Biol       Date:  2019-11-14       Impact factor: 4.652

Review 4.  DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases.

Authors:  U Zekonyte; S R Bacman; C T Moraes
Journal:  J Intern Med       Date:  2020-04-27       Impact factor: 8.989

5.  CRISPR/Cas9-mediated mutagenesis at microhomologous regions of human mitochondrial genome.

Authors:  Bang Wang; Xiujuan Lv; Yufei Wang; Zhibo Wang; Qi Liu; Bin Lu; Yong Liu; Feng Gu
Journal:  Sci China Life Sci       Date:  2021-01-06       Impact factor: 6.038

Review 6.  Mitochondrial noncoding RNAs: new wine in an old bottle.

Authors:  Huixin Liang; Jiayu Liu; Shicheng Su; Qiyi Zhao
Journal:  RNA Biol       Date:  2021-06-10       Impact factor: 4.766

7.  A Versatile Solid-Phase Approach to the Synthesis of Oligonucleotide Conjugates with Biodegradable Hydrazone Linker.

Authors:  Mariya I Meschaninova; Nina S Entelis; Elena L Chernolovskaya; Alya G Venyaminova
Journal:  Molecules       Date:  2021-04-07       Impact factor: 4.411

Review 8.  Advancing organelle genome transformation and editing for crop improvement.

Authors:  Shengchun Li; Ling Chang; Jiang Zhang
Journal:  Plant Commun       Date:  2021-01-04

Review 9.  Strategies for mitochondrial gene editing.

Authors:  Xingbo Yang; Jiacheng Jiang; Zongyu Li; Jiayi Liang; Yaozu Xiang
Journal:  Comput Struct Biotechnol J       Date:  2021-06-04       Impact factor: 7.271

Review 10.  Therapeutic Options in Hereditary Optic Neuropathies.

Authors:  Giulia Amore; Martina Romagnoli; Michele Carbonelli; Piero Barboni; Valerio Carelli; Chiara La Morgia
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.